2010 AnnuAl REpoRT - Ciberdem
2010 AnnuAl REpoRT - Ciberdem
2010 AnnuAl REpoRT - Ciberdem
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Proteomic analysis of plasma in the polycystic ovary<br />
syndrome identifies novel markers involved in iron<br />
metabolism, acute-phase response, and inflammation<br />
Insenser M, Martínez-García MA, Montes R, San-Millán JL,<br />
Escobar-Morreale HF<br />
J Clin Endocrinol Metab, 95, 3863-3870 (<strong>2010</strong>)<br />
IF: 6.202 first decile<br />
The determinants of insulin sensitivity, β-cell function,<br />
and glucose tolerance are different in patients with<br />
polycystic ovary syndrome than in women who do not have<br />
hyperandrogenism<br />
Luque-Ramírez M, Alpañés M, Escobar-Morreale HF<br />
Fertil Steril, 94, 2214-2221 (<strong>2010</strong>)<br />
IF: 3.970 first decile<br />
The role of genetic variation in peroxisome proliferatoractivated<br />
receptors in the polycystic ovary syndrome<br />
(PCOS): an original case-control study followed by<br />
systematic review and meta-analysis of existing evidence<br />
San-Millán JL, Escobar-Morreale HF<br />
Clin Endocrinol, 72, 383-392 (<strong>2010</strong>)<br />
IF: 3.201 second quartile<br />
frente a un anticonceptivo oral más un antiandrógeno<br />
(espironolactona). Phase II<br />
ENDOPCOS 02/2008: <strong>2010</strong>-ongoing<br />
Name of the participants: HF Escobar Morreale (coordinator<br />
and researcher), M Alpañés Buesa and M Luque Ramírez<br />
(researchers)<br />
Clinical practice guidelines<br />
Assessment of cardiovascular risk and prevention of<br />
cardiovascular disease in women with the polycystic ovary<br />
syndrome: a position statement by the Androgen Excess &<br />
Polycystic Ovary Syndrome (AE-PCOS) Society<br />
Journal of Clinical Endocrinology & Metabolism, 95, 2038-<br />
2049 (<strong>2010</strong>)<br />
Institution: Androgen Excess & Polycystic Ovary Syndrome<br />
(AE-PCOS) Society<br />
Authors: RA Wild, E Carmina, E Diamanti-Kandarakis, A<br />
Dokras, HF Escobar Morreale, W Futterweit, R Lobo, RJ<br />
Norman, E Talbott, DA Dumesic<br />
Treatment of polycystic ovary syndrome (PCOS) with<br />
metformin ameliorates insulin resistance in parallel with the<br />
decrease of serum interleukin-6 concentrations<br />
Luque-Ramírez M, Escobar-Morreale HF<br />
Horm Metab Res, 42, 815-820 (<strong>2010</strong>)<br />
IF: 2.686 second quartile<br />
Research grants<br />
National project<br />
Influencia de los andrógenos en el desarrollo de la<br />
adiposidad abdominal y de la disfunción metabólica<br />
del tejido adiposo visceral en humanos, como factores<br />
etiopatogénicos de la resistencia insulínica y la diabetes<br />
Instituto de Salud Carlos III, Fondo de Investigación<br />
Sanitaria, PI081147: 2009-2011<br />
Principal Investigator: Héctor F Escobar Morreale<br />
Scientific collaborations within CIBERDEM<br />
Determinants of insulin resistance and glucose tolerance<br />
disorders, including diabetes, in severe obesity and their<br />
changes after bariatric surgery-induced weight loss<br />
DIASOBS: 2009-<strong>2010</strong><br />
Coordinator: Héctor F Escobar Morreale<br />
CIBERDEM groups: HF Escobar Morreale, X Correig, E<br />
Montanya, R Simó, J Vendrell<br />
Clinical trials<br />
Protocolo de investigación sobre el perfil de riesgo<br />
cardiovascular asociado a mujeres con síndrome de<br />
ovario poliquístico o hiperandrogenismo ovulatorio, y<br />
evolución del mismo durante el tratamiento con metformina<br />
Representative Cy2-labelled internal standard proteome map indicating<br />
the proteins altered in PCOS. The four protein spots found<br />
significantly increased in the plasma samples from PCOS patients<br />
(P
Change language